Leiutis in the media.
The latest from Leiutis Pharmaceuticals.
Explore news, media coverage, articles and updates about Leiutis Pharmaceuticals, its scientific work and developments around its products.
Explore latest coverage
CDSCO approves Leiutis Pharma’s synthetic CBD oral solution for mild to moderate anxiety disorders
Read article
The next frontier in anxiety care: Synthetic CBD arrives
Read article
Leiutis Pharmaceuticals announces CDSCO approval for synthetic CBD oral solution for mild to moderate anxiety disorders

Leiutis Pharmaceuticals announces CDSCO approval for World’s First Synthetic CBD Therapy for Mild to Moderate Anxiety Disorders

India approves world’s first synthetic CBD oral solution for anxiety treatment
Read article
World’s First Synthetic CBD Oral Therapy for Anxiety Gets CDSCO Nod, Offering New Treatment Option
Read article
Leiutis Pharmaceuticals announces CDSCO approval for global-first synthetic CBD therapy for mild to moderate anxiety disorders
Read article
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety Disorders
Read article
Leiutis Pharma gets CDSCO nod

India Approves World’s First Synthetic CBD Therapy For Anxiety Disorders
Read article
Leiutis Pharma announces CDSCO approval for global-first synthetic CBD therapy to cure mild to moderate anxiety disorders
Read article
Leiutis Pharma gets CDSCO nod for global-first synthetic CBD therapy for mild to moderate anxiety disorders
Read article
CDSCO approves India-developed synthetic Cannabidiol Oral Solution for anxiety disorders
Read article
India Approves World’s First Synthetic CBD Oral Therapy for Anxiety Disorders
Read article
Leiutis Pharma Wins CDSCO Approval for World’s First Synthetic CBD Anxiety Therapy
Read article
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety Disorders
Read article
India Creates Global First as CDSCO Clears Synthetic CBD Therapy
Read article
LEIUTIS PHARMACEUTICALS ANNOUNCES CDSCO APPROVAL FOR GLOBAL-FIRST SYNTHETIC CBD THERAPY FOR MILD TO MODERATE ANXIETY DISORDERS
Read article
Leiutis Pharma Gets CDSCO Nod for World’s First Synthetic CBD Drug
Read article
Leiutis announces CDSCO approval for synthetic CBD therapy for anxiety disorders
Read article
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety Disorders
Read article
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety Disorders
Read article

